BENEV Company Inc. is a US FDA-registered pharmaceutical, cosmeceutical, and medical device company. While BENEV has a growing range of clinically proven products, its “Regenerative Trifecta” is undoubtedly a practitioner favorite. The Regenerative Trifecta comprises Sylfirm X, the world’s first dual wave radiofrequency microneedling device; high tensile strength Miracu® PDO threads; and a regenerative line of Exosomes by BENEV. Similarly, a trio of key features led these BENEV products to the top: advanced manufacturing methods, state-of-the-art technologies, and premier customization abilities.
BENEV was established in 2000. Today, there are over 300 Sylfirm X users, 250 Miracu® users, and 1,200 Exosomes users. Medical aesthetic practitioners have BENEV at the forefront of their practices, and trusted industry publications have taken note. NewBeauty magazine is the digital authority of the beauty world—reporting on makeup trends, the best skincare buys, aesthetic treatments, and the like. All content is backed by experts and scientifically grounded, so BENEV was proud to partner with them to promote the Regenerative Trifecta.
Starting off strong with Sylfirm X
Dermatologist approved, indeed. BENEV Key Opinion Leader (KOL), Renato Saltz, MD, joins Ashley Macgovern, MD, dermatologist and Sylfirm X practitioner, to weigh in on this “anti-aging treatment.” Sylfirm is far more than just another RF microneedling device; it is the first dual wave RFMN technology with continuous wave (CW) and pulsed wave (PW) modes that treat a wider range of skin types and conditions—while optimizing patient comfortability and downtime. NewBeauty’s Sylfirm X feature delivers an expert point of view on all the basics, recommended treatment plans, which patients are ideal candidates, what to expect for downtime and possible side effects, and more. Read the full article here.
BENEV Exosomes for less downtime and better results
The one downside to medical aesthetic treatments is downtime. In a world of instant gratification (hello, high speed internet and fast food drive-throughs), downtime can be a real, well, downer as patients are instructed to reschedule social gatherings, stay indoors, or pause their normal skin, exercise, and makeup routines.
In an effort to turn this downside into an upside, BENEV spent 20 years researching, developing, and perfecting the Exosome Regenerative Complex (ERC), Exosome Regenerative Complex + (ERC+), and BENEV EXO Balm. And this extensive research paid off! BENEV’s Chief Medical Director, Richard Jin, MD, and Suneel Chilukuri, MD, FAAD, FACMS, a board-certified dermatologist and the newest member to BENEV’s Medical Advisory Board (MAB), share their first-hand experiences with BENEV Exosomes and tips for incorporating these regenerative solutions into your practice.
Nonsurgical facial reconstruction using Miracu® PDO threads
